| （単位：千ドル） | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | - | 11,786 | 10,842 | 13,455 | 9,804 | 2,580 | 438 | 20,180 | 12,100 | 14,419 | 23,704 | - | - |
| 営業費用 | - | 16,490 | 16,320 | 18,450 | 15,177 | 7,234 | 3,737 | 25,125 | 17,328 | 18,958 | 31,462 | - | - |
| 営業利益 | -501 | -16,490 | -16,320 | -18,450 | -15,177 | -7,234 | -3,737 | -25,125 | -17,328 | -18,958 | -31,462 | - | - |
| 経常（税引前）利益 | -500 | - | - | - | - | - | - | -22,758 | -15,923 | -14,102 | -26,944 | - | - |
| 法人税等合計 | - | - | - | - | - | - | - | 23 | 24 | 20 | 5 | - | - |
| 実効税率（％） | - | - | - | - | - | - | - | - | - | ||||
| 純利益 | -500 | -19,048 | -16,447 | -18,551 | -15,231 | -7,090 | -3,277 | -22,781 | -15,947 | -14,122 | -26,949 | -26,599 | -34,085 |
| 一株あたり利益 | - | - | - | - | - | -0.16 | -0.08 | -1.2 | -0.74 | -0.58 | -1.09 | - | - |
| 希薄化後一株あたり利益 | - | - | - | - | - | -0.16 | -0.08 | -1.2 | -0.74 | -0.58 | -1.09 | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - |